A novel antimicrobial endolysin, LysPA26, against Pseudomonas aeruginosa

Frontiers in Microbiology

Volumn 8, Issue FEB, 2017, Pages

  Guo, Mingquan ^a   Feng, Chunyan ^b   Ren, Jie ^a   Zhuang, Xuran ^a   Zhang, Yan ^a   Zhu, Yongzhang ^a   Dong, Ke ^a   He, Ping ^a   Guo, Xiaokui ^a   Qin, Jinhong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b PEOPLE S HOSPITAL OF HANGZHOU MEDICAL COLLEGE   (China)

Author keywords

Antimicrobial agent; Bacteriophage; Endolysin; LysPA26; Pseudomonas aeruginosa

Indexed keywords

ANTIINFECTIVE AGENT; LYSPA26; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIOPHAGE; BIOFILM; CONTROLLED STUDY; ESCHERICHIA COLI; GENE OVEREXPRESSION; GENOME ANALYSIS; KLEBSIELLA PNEUMONIAE; MICROBIAL GROWTH; MOLECULAR CLONING; NONHUMAN; PROTEIN PURIFICATION; PSEUDOMONAS AERUGINOSA; TRANSMISSION ELECTRON MICROSCOPY;

EID: 85014424822     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2017.00293     Document Type: Article

References (37)

1. Alemayehu, D., Casey, P. G., McAuliffe, O., Guinane, C. M., Martin, J. G., Shanahan, F., et al. (2012). Bacteriophages phiMR299-2 and phiNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. MBio 3:e00029-12. doi: 10.1128/mBio.00029-12.
2. Azeredo, J., and Sutherland, I. W. (2008). The use of phages for the removal of infectious biofilms. Curr. Pharm. Biotechnol. 9, 261-266.
3. Boss, R., Overesch, G., and Baumgartner, A. (2016). Antimicrobial resistance of Escherichia coli, Enterococci, Pseudomonas aeruginosa, and Staphylococcus aureus from raw fish and seafood imported into Switzerland. J. Food Prot. 79, 1240-1246. doi: 10.4315/0362-028x.jfp-15-463.
4. Briers, Y., Volckaert, G., Cornelissen, A., Lagaert, S., Michiels, C. W., Hertveldt, K., et al. (2007). Muralytic activity and modular structure of the endolysins of Pseudomonas aeruginosa bacteriophages phiKZ and EL. Mol. Microbiol. 65, 1334-1344. doi: 10.1111/j.1365-2958.2007.05870.x.
5. Briers, Y., Walmagh, M., Grymonprez, B., Biebl, M., Pirnay, J. P., Defraine, V., et al. (2014). Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 58, 3774-3784. doi: 10.1128/aac.02668-14.
6. Briers, Y., Walmagh, M., and Lavigne, R. (2011). Use of bacteriophage endolysin EL188 and outer membrane permeabilizers against Pseudomonas aeruginosa. J. Appl. Microbiol. 110, 778-785. doi: 10.1111/j.1365-2672.2010.04931.x.
7. Costerton, J. W., Stewart, P. S., and Greenberg, E. P. (1999). Bacterial biofilms: a common cause of persistent infections. Science 284, 1318-1322.
8. del Pozo, J. L., and Patel, R. (2007). The challenge of treating biofilm-associated bacterial infections. Clin. Pharmacol. Ther. 82, 204-209. doi: 10.1038/sj.clpt.6100247.
9. Donlan, R. M., and Costerton, J. W. (2002). Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15, 167-193. doi: 10.1128/cmr.15.2.167-193.2002.
10. Fischetti, V. A. (2005). Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbiol. 13, 491-496. doi: 10.1016/j.tim.2005.08.007.
11. Fischetti, V. A. (2010). Bacteriophage endolysins: a novel anti-infective to control gram-positive pathogens. Int. J. Med. Microbiol. 300, 357-362. doi: 10.1016/j.ijmm.2010.04.002.
12. Fu, W., Forster, T., Mayer, O., Curtin, J. J., Lehman, S. M., and Donlan, R. M. (2010). Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob. Agents Chemother. 54, 397-404. doi: 10.1128/aac.00669-09.
13. Helander, I. M., and Mattila-Sandholm, T. (2000). Fluorometric assessment of gram-negative bacterial permeabilization. J. Appl. Microbiol. 88, 213-219.
14. Hermoso, J. A., Garcia, J. L., and Garcia, P. (2007). Taking aim on bacterial pathogens: from phage therapy to enzybiotics. Curr. Opin. Microbiol. 10, 461-472. doi: 10.1016/j.mib.2007.08.002.
15. Keen, E. C. (2012). Phage therapy: concept to cure. Front. Microbiol. 3:238. doi: 10.3389/fmicb.2012.00238.
16. Kwan, T., Liu, J., Dubow, M., Gros, P., and Pelletier, J. (2006). Comparative genomic analysis of 18 Pseudomonas aeruginosa bacteriophages. J. Bacteriol. 188, 1184-1187. doi: 10.1128/jb.188.3.1184-1187.2006.
17. Lai, M. J., Lin, N. T., Hu, A., Soo, P. C., Chen, L. K., Chen, L. H., et al. (2011). Antibacterial activity of Acinetobacter baumannii phage varphiAB2 endolysin (LysAB2) against both gram-positive and gram-negative bacteria. Appl. Microbiol. Biotechnol. 90, 529-539. doi: 10.1007/s00253-011-3104-y.
18. Li, J. W., and Vederas, J. C. (2009). Drug discovery and natural products: end of an era or an endless frontier? Science 325, 161-165. doi: 10.1126/science.1168243.
19. Li, X. Z., Plesiat, P., and Nikaido, H. (2015). The challenge of efflux-mediated antibiotic resistance in gram-negative bacteria. Clin. Microbiol. Rev. 28, 337-418. doi: 10.1128/cmr.00117-14.
20. Lim, J. A., Shin, H., Heu, S., and Ryu, S. (2014). Exogenous lytic activity of SPN9CC endolysin against gram-negative bacteria. J. Microbiol. Biotechnol. 24, 803-811.
21. Lin, N.-T., Chiou, P.-Y., Chang, K.-C., Chen, L.-K., and Lai, M.-J. (2010). Isolation and characterization of fAB2: a novel bacteriophage of Acinetobacter baumannii. Res. Microbiol. 161, 308-314. doi: 10.1016/j.resmic.2010.03.007.
22. Lood, R., Winer, B. Y., Pelzek, A. J., Diez-Martinez, R., Thandar, M., Euler, C. W., et al. (2015). Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model. Antimicrob. Agents Chemother. 59, 1983-1991. doi: 10.1128/aac.04641-14.
23. Lyczak, J. B., Cannon, C. L., and Pier, G. B. (2000). Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect. 2, 1051-1060.
24. Nelson, D., Loomis, L., and Fischetti, V. A. (2001). Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc. Natl. Acad. Sci. U.S.A. 98, 4107-4112. doi: 10.1073/pnas.061038398.
25. Oliveira, H., Thiagarajan, V., Walmagh, M., Sillankorva, S., Lavigne, R., Neves-Petersen, M. T., et al. (2014). A thermostable Salmonella phage endolysin, Lys68, with broad bactericidal properties against gram-negative pathogens in presence of weak acids. PLoS ONE 9:e108376. doi: 10.1371/journal.pone.0108376.
26. Paradis-Bleau, C., Cloutier, I., Lemieux, L., Sanschagrin, F., Laroche, J., Auger, M., et al. (2007). Peptidoglycan lytic activity of the Pseudomonas aeruginosa phage phiKZ gp144 lytic transglycosylase. FEMS Microbiol. Lett. 266, 201-209. doi: 10.1111/j.1574-6968.2006.00523.x.
27. Pires, D., Sillankorva, S., Faustino, A., and Azeredo, J. (2011). Use of newly isolated phages for control of Pseudomonas aeruginosa PAO1 and ATCC 10145 biofilms. Res. Microbiol. 162, 798-806. doi: 10.1016/j.resmic.2011.06.010.
28. Pires, D. P., Cleto, S., Sillankorva, S., Azeredo, J., and Lu, T. K. (2016). Genetically engineered phages: a review of advances over the last decade. Microbiol. Mol. Biol. Rev. 80, 523-543. doi: 10.1128/MMBR.00069-15.
29. Rodriguez, L., Martinez, B., Zhou, Y., Rodriguez, A., Donovan, D. M., and Garcia, P. (2011). Lytic activity of the virion-associated peptidoglycan hydrolase HydH5 of Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88. BMC Microbiol. 11:138. doi: 10.1186/1471-2180-11-138.
30. Sass, P., and Bierbaum, G. (2007). Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus. Appl. Environ. Microbiol. 73, 347-352. doi: 10.1128/aem.01616-06.
31. Schuch, R., Nelson, D., and Fischetti, V. A. (2002). A bacteriolytic agent that detects and kills Bacillus anthracis. Nature 418, 884-889. doi: 10.1038/nature01026.
32. Twort, F. W. (1915). An investigation on the nature of ultra-microscopic viruses. Lancet 186, 1241-1243. doi: 10.1016/S0140-6736(01)20383-3.
33. Vaara, M. (1992). Agents that increase the permeability of the outer membrane. Microbiol. Rev. 56, 395-411.
34. Walmagh, M., Boczkowska, B., Grymonprez, B., Briers, Y., Drulis-Kawa, Z., and Lavigne, R. (2013). Characterization of five novel endolysins from gram-negative infecting bacteriophages. Appl. Microbiol. Biotechnol. 97, 4369-4375. doi: 10.1007/s00253-012-4294-7.
35. Walmagh, M., Briers, Y., dos Santos, S. B., Azeredo, J., and Lavigne, R. (2012). Characterization of modular bacteriophage endolysins from Myoviridae phages OBP, 201phi2-1 and PVP-SE1. PLoS ONE 7:e36991. doi: 10.1371/journal.pone.0036991.
36. Xavier, J. B., Picioreanu, C., Rani, S. A., van Loosdrecht, M. C., and Stewart, P. S. (2005). Biofilm-control strategies based on enzymic disruption of the extracellular polymeric substance matrix-a modelling study. Microbiology 151(Pt 12), 3817-3832. doi: 10.1099/mic.0.28165-0.
37. Young, R., and Gill, J. J. (2015). MICROBIOLOGY. Phage therapy redux-What is to be done? Science 350, 1163-1164. doi: 10.1126/science.aad6791.